JPMORGAN CHASE & CO - SAVIENT PHARMACEUTICALS INC ownership

SAVIENT PHARMACEUTICALS INC's ticker is and the CUSIP is 80517QAA8. A total of 18 filers reported holding SAVIENT PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SAVIENT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2013$422,000
-4.3%
2,207,000
+0.0%
0.00%
Q2 2013$441,0002,206,0000.00%
Other shareholders
SAVIENT PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 30,476,000$7,314,0003.62%
Knighthead Capital Management, LLC 6,400,000$1,224,0000.23%
Hatteras Alternative Mutual Funds, LLC 500,000$96,0000.06%
P SCHOENFELD ASSET MANAGEMENT LP 5,000,000$869,0000.06%
RA Capital Management 1,000,000$193,0000.02%
SCOGGIN MANAGEMENT LP 1,000,000$191,0000.02%
CITIGROUP INC 20,428,000$3,907,0000.00%
SIGNATUREFD, LLC 40,000$8,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 36,591,000$6,998,0000.00%
BNP PARIBAS FINANCIAL MARKETS 110,000$2,103,750,0000.00%
View complete list of SAVIENT PHARMACEUTICALS INC shareholders